Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Farde

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
Psychopharmacology|January 1, 1989
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsL Farde, F A Wiesel, A L Nordström, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Central D1- and D2-receptor occupancy during antipsychotic drug treatmentF A Wiesel, L Farde, A L Nordström, et al.
Synapse (New York, N.Y.)|October 25, 2000
Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907H Hall, L Farde, C Halldin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Raclopride, a new selective ligand for the dopamine-D2 receptorsH Hall, C Köhler, L Gawell, et al.
The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.
Psychopharmacology|October 20, 1999
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brainY H Chou, P Karlsson, C Halldin, et al.
Nuclear Medicine and Biology|June 26, 1999
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positionsC Lundkvist, C Halldin, C G Swahn, et al.
Nuclear Medicine and Biology|November 14, 1997
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporterC Lundkvist, C Halldin, N Ginovart, et al.
Psychopharmacology|October 1, 1995
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in manP Karlsson, G Sedvall, C Halldin, et al.
International Clinical Psychopharmacology|April 1, 1989
The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy malesL Farde, C von Bahr, A Wahlen, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
Psychopharmacology|January 1, 1989
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsL Farde, F A Wiesel, A L Nordström, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Central D1- and D2-receptor occupancy during antipsychotic drug treatmentF A Wiesel, L Farde, A L Nordström, et al.
Synapse (New York, N.Y.)|October 25, 2000
Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907H Hall, L Farde, C Halldin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Raclopride, a new selective ligand for the dopamine-D2 receptorsH Hall, C Köhler, L Gawell, et al.
The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.
Psychopharmacology|October 20, 1999
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brainY H Chou, P Karlsson, C Halldin, et al.
Nuclear Medicine and Biology|June 26, 1999
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positionsC Lundkvist, C Halldin, C G Swahn, et al.
Nuclear Medicine and Biology|November 14, 1997
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporterC Lundkvist, C Halldin, N Ginovart, et al.
Psychopharmacology|October 1, 1995
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in manP Karlsson, G Sedvall, C Halldin, et al.
International Clinical Psychopharmacology|April 1, 1989
The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy malesL Farde, C von Bahr, A Wahlen, et al.
Pageof 21